New cervical cancer screening guidelines recommend HPV testing over Pap tests

For the first time, the federal directive is set to direct women ages 30 to 65 to get an HPV test rather than the traditional Pap test. Women can also opt for a self-administered HPV test, a major change from the U.S. Preventive Services Task Force that could affect how millions of women are screened for cervical cancer.

Cervical cancer is one of the most preventable cancers, although recent research suggests the United States is regressing in its efforts to detect the disease early. Human papillomavirus, the virus responsible for virtually all cervical cancers, is the most common sexually transmitted infection.

The recommendation, which is not yet final, was made Friday when panel members voted behind closed doors following a two-day meeting, according to a person familiar with the vote. The person asked to speak on condition of anonymity because they were not authorized to speak publicly.

The recommendation of the task force – an external group made up primarily of primary care doctors – carries real weight. Under the Affordable Care Act, most private insurers generally must cover services recommended by the panel at no cost to patients.

A spokesperson for the task force did not respond to a request for comment.

Under the task force’s previous recommendations, women ages 30 to 65 could choose between three options: a Pap test every three years, an HPV test every five years, or both every five years.

The task force continues to recommend that women ages 21 to 29 get a Pap test every three years.

Dr. Sangini Sheth, associate professor of obstetrics, gynecology and reproductive sciences at the Yale School of Medicine, said the self-collection option could increase women’s access to screening.

“Self-sampling is ideal for people who might have difficulty tolerating a speculum exam, and it also expands our ability to offer screening in different scenarios, through mobile health clinics, perhaps through an independent laboratory, or in specialty medical offices where pelvic exams are not traditionally performed,” she said.

Robert Smith, cancer epidemiologist and senior vice president of early cancer detection science for the American Cancer Society, said, “Collecting a sample is fairly easy to do and its accuracy is really equivalent to a sample collected by a doctor. »

For decades, the Pap test, which looks for abnormal or precancerous cells on the cervix, has been the primary way doctors screen for cervical cancer. Instead, an HPV test looks for high-risk strains of HPV, which are often visible before cellular abnormalities develop, allowing women to go more time between tests.

A 2018 study published in the Journal of the American Medical Association found that HPV tests detect precancerous changes in the cervix earlier and more accurately than Pap tests. The study included more than 19,000 women.

Smith said some women put off getting the Pap test because they are uncomfortable or find the exam invasive, especially when it is performed by a male doctor. Self-collected HPV tests – which use a simple vaginal swab rather than a speculum – are generally more comfortable.

“We hope (the self-collection test) will increase screening,” he added.

Many women get both tests together, but most of the benefits come from the HPV test, Sheth said. The Pap test alone misses a significant portion of abnormalities, she said, detecting about 50 to 70 percent of them. Women who skip HPV testing are much more likely to have an HPV-related problem that goes undetected.

“There’s really no downside to not having this Pap,” she said.

“It’s superior to the cost testing,” Smith said, referring to the HPV test.

The task force’s recommendations are generally final once published, and it is unclear when that will happen.

It’s also unclear whether Health Secretary Robert F. Kennedy Jr. will have to sign on or seek to make changes after the Supreme Court ruled last year that he had authority over the panel. In that case, brought by a Christian company that had objected to coverage of an HIV prevention drug, the court upheld the committee’s authority because the health secretary can remove its members and review their recommendations.

In September, Kennedy reshuffled the panel, appointing eight new members, some of whom own shares in companies making drugs and other products affected by the panel’s decisions, according to documents reviewed by The New York Times. NBC News has not independently reviewed the documents. Thursday’s meeting was the committee’s first in more than a year.

A spokesperson for the Department of Health and Human Services did not immediately respond to a request for comment.

Smith said the task force’s recommendation brings it closer to the American Cancer Society’s guidelines, which began prioritizing HPV testing in 2020.

There are still some differences: The Cancer Society recommends starting screening at age 25 with HPV testing, while the task force recommends starting at age 21 with Pap tests and switching to HPV testing at age 30. And for women who collect their own samples, the cancer society recommends getting tested every three years, not five, because it wants longer-term data before recommending a longer interval, Smith said.

The working group also clarified Thursday which women should stop screening at age 65: only if they have had several consecutive negative results over the past decade. Women who have not done so should continue to get tested, the panel said.

In a statement, a spokesperson for the American College of Obstetricians and Gynecologists said the group is “monitoring the USPSTF’s process to change cervical cancer screening recommendations and will evaluate the final proposed changes when they become available.”

Gn Health

Logo